Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000320358) titled 'A Study to Assess the Effect of Acid-Reducing Medicines on ATH434 in Healthy Volunteers' on March 13.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Crossover
Primary Sponsor: Alterity Therapeutics Limited
Condition:
Multiple System Atrophy (MSA)
Multiple System Atrophy (MSA)
Neurological - Neurodegenerative diseases
Intervention:
Period 1 (Day 1-2) is the control period.
Intervention: In Period 2 (Day 3-7) participants will receive one esomeprazole 40mg capsule given orally on each of Days 3-6), followed by one ...